Mouse N-acetyltransferase type 2, the homologue of human N-acetyltransferase type 1

Biochemical Pharmacology

Volumn 75, Issue 7, 2008, Pages 1550-1560

  Kawamura, Akane ^a   Westwood, Isaac ^a   Wakefield, Larissa ^a   Long, Hilary ^a   Zhang, Naixia ^b   Walters, Kylie ^b   Redfield, Christina ^a   Sim, Edith ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Arylamine N acetyltransferase NAT; Breast cancer; Enzyme inhibition; Selective estrogen receptor modulator SERM; Steroid; Xenobiotic

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ACYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE; BIOLOGICAL MARKER; DIETHYLSTILBESTROL; DRUG METABOLIZING ENZYME; ENZYME INHIBITOR; GENISTEIN; N ACETYLTRANSFERASE 1; N ACETYLTRANSFERASE 2 INHIBITOR; PROTEIN; RECOMBINANT ARYLAMINE ACETYLTRANSFERASE; RECOMBINANT PROTEIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STEROID; TAMOXIFEN; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; BIOLOGICAL ACTIVITY; BREAST CANCER; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; ENZYME STRUCTURE; HUMAN; LIGAND BINDING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTON TRANSPORT; SEQUENCE HOMOLOGY;

EID: 40649109723     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.12.012     Document Type: Article

References (49)

1. E. Sim I. Westwood E. Fullam Arylamine N -acetyltransferases Expert Opin. Drug Metab. Toxicol. 3 2007 169 184
2. A. Kawamura J. Graham A. Mushtaq S.A. Tsiftsoglou G.M. Vath P.E. Hanna Eukaryotic arylamine N -acetyltransferase Investigation of substrate specificity by high-throughput screening Biochem. Pharmacol. 69 2005 347 359
3. S. Gruvberger M. Ringner Y. Chen S. Panavally L.H. Saal A. Borg Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns Cancer Res. 61 2001 5979 5984
4. K.R. Hess K. Anderson W.F. Symmans V. Valero N. Ibrahim J.A. Mejia Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer J. Clin. Oncol. 24 2006 4236 4244
5. L.D. Miller J. Smeds J. George V.B. Vega L. Vergara A. Ploner An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival Proc. Natl. Acad. Sci. U.S.A. 102 2005 13550 13555
6. C.M. Perou S.S. Jeffrey M. van de Rijn C.A. Rees M.B. Eisen D.T. Ross Distinctive gene expression patterns in human mammary epithelial cells and breast cancers Proc. Natl. Acad. Sci. U.S.A. 96 1999 9212 9217
7. J.R. Pollack T. Sorlie C.M. Perou C.A. Rees S.S. Jeffrey P.E. Lonning Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors Proc. Natl. Acad. Sci. U.S.A. 99 2002 12963 12968
8. A.L. Richardson Z.C. Wang A. De Nicolo X. Lu M. Brown A. Miron X chromosomal abnormalities in basal-like human breast cancer Cancer Cell 9 2006 121 132
9. M.J. van de Vijver Y.D. He L.J. van’t Veer H. Dai A.A. Hart D.W. Voskuil A gene-expression signature as a predictor of survival in breast cancer N. Engl. J. Med. 347 2002 1999 2009
10. Y. Wang J.G. Klijn Y. Zhang A.M. Sieuwerts M.P. Look F. Yang Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 365 2005 671 679
11. K. Yu K. Ganesan L.D. Miller P. Tan A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors Clin Cancer Res. 12 2006 3288 3296
12. H. Zhao A. Langerod Y. Ji K.W. Nowels J.M. Nesland R. Tibshirani Different gene expression patterns in invasive lobular and ductal carcinomas of the breast Mol. Biol. Cell 15 2004 2523 2536
13. P.J. Adam J. Berry J.A. Loader K.L. Tyson G. Craggs P. Smith Arylamine N -acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro Mol. Cancer Res. 1 2003 826 835
14. L. Wakefield J. Robinson H. Long J.C. Ibbitt S. Cooke H.C. Hurst Arylamine N -acetyltransferase I expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors Genes Chromosomes Cancer 47 2008 118 126
15. J.H. Lee J.G. Chung J.M. Lai G.N. Levy W.W. Weber Kinetics of arylamine N -acetyltransferase in tissues from human breast cancer Cancer Lett. 111 1997 39 50
16. J.H. Lee H.F. Lu D.Y. Wang D.R. Chen C.C. Su Y.S. Chen Effects of tamoxifen on DNA adduct formation and arylamines N -acetyltransferase activity in human breast cancer cells Res. Commun. Mol. Pathol. Pharmacol. 115–116 2004 217 233
17. K.H. Lu K.L. Lin T.C. Hsia C.F. Hung M.C. Chou Y.M. Hsiao Tamoxifen inhibits arylamine N -acetyltransferase activity and DNA-2-aminofluorene adduct in human leukemia HL-60 cells Res. Commun. Mol. Pathol. Pharmacol. 109 2001 319 331
18. J.V. Alvarez D. Perez L.A. Chodosh mILC-ing the mouse mammary gland: a model for invasive lobular carcinoma Cancer Cell 10 2006 347 349
19. N.E. Sharpless R.A. Depinho The mighty mouse: genetically engineered mouse models in cancer drug development Nat. Rev. Drug Discov. 5 2006 741 754
20. L. Wakefield V. Cornish H. Long A. Kawamura X. Zhang D.W. Hein Mouse arylamine N -acetyltransferase 2 (Nat2) expression during embryogenesis: a potential marker for the developing neuroendocrine system Biomarkers 13 2008 106 118
21. J.A. Williams E.M. Stone G. Fakis N. Johnson J.A. Cordell W. Meinl N -Acetyltransferases, sulfotransferases and heterocyclic amine activation in the breast Pharmacogenetics 11 2001 373 388
22. S.L. Kelly E. Sim Arylamine N -acetyltransferase in Balb/c mice: identification of a novel mouse isoenzyme by cloning and expression in vitro Biochem. J. 302 Pt 2 1994 347 353
23. H. Wang G.M. Vath K.J. Gleason P.E. Hanna C.R. Wagner Probing the mechanism of hamster arylamine N -acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies Biochemistry 43 2004 8234 8246
24. J. Sinclair R. Delgoda M. Noble S. Jarmin N. Goh E. Sim Purification, characterisation and crystallisation of an N -hydroxyarylamine O -acetyltransferase from Salmonella typhimurium Prot. Exp. Purific. 12 1998 371 380
25. J. Sinclair E. Sim A fragment consisting of the first 204 amino-terminal amino acids of human arylamine N -acetyltransferase one (NAT1) and the first transacetylation step of catalysis Biochem. Pharmacol. 53 1997 11 16
26. E.W. Brooke S.G. Davies A.W. Mulvaney F. Pompeo E. Sim R.J. Vickers An approach to identifying novel substrates of bacterial arylamine N -acetyltransferases Bioorg. Med. Chem. 11 2003 1227 1234
27. K. Martell G. Levy W. Weber Cloned mouse N -acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products Mol. Pharmacol. 42 1992 265 272
28. L. Estrada-Rodgers G. Levy W. Weber Substrate selectivity of mouse N -acetyltransferases 1, 2 and 3 expressed in Cos-1 cells Drug Metab. Dispos. 26 1998 502 505
29. G.N. Levy K.J. Martell J.H. DeLeon W.W. Weber Metabolic, molecular genetic and toxicological aspects of the acetylation polymorphism in inbred mice Pharmacogenetics 2 1992 197 206
30. H. Wu L. Dombrovsky W. Tempel F. Martin P. Loppnau G.H. Goodfellow Structural basis of substrate-binding specificity of human arylamine N -acetyltransferases J. Biol. Chem. 282 2007 30189 30197
31. M. Payton A. Mushtaq T.W. Yu L.J. Wu J. Sinclair E. Sim Eubacterial arylamine N -acetyltransferases—identification and comparison of 18 members of the protein family with conserved active site cysteine, histidine and aspartate residues Microbiology 147 2001 1137 1147
32. E. Fullam I.M. Westwood M.C. Anderton E.D. Lowe E. Sim M.E. Noble Divergence of co-factor recognition across evolution: coenzyme A binding in a prokaryotic arylamine N -acetyltransferase J Mol Biol 375 2008 178 191
33. A. Sali T.L. Blundell Comparative protein modelling by satisfaction of spatial restraints J. Mol. Biol. 234 1993 779 815
34. N. Zhang L. Liu F. Liu C.R. Wagner P.E. Hanna K.J. Walters NMR-based model reveals the structural determinants of mammalian arylamine N -acetyltransferase substrate specificity J. Mol. Biol. 363 2006 188 200
35. H. Wang L. Liu P.E. Hanna C.R. Wagner Catalytic mechanism of hamster arylamine N -acetyltransferase 2 Biochemistry 44 2005 11295 11306
36. V.A. Cornish K. Pinter S. Boukouvala N. Johnson C. Labrousse M. Payton Generation and analysis of mice with a targeted disruption of the arylamine N -acetyltransferase type 2 gene Pharmacogenom. J. 3 2003 169 177
37. L. Wakefield A. Kawamura H. Long E. Sim Neuroendocrine expression of mouse arylamine N -acetyltransferase 2 Genet. Res. 88 2006 67 76
38. L. Wakefield V. Cornish H. Long W.J. Griffiths E. Sim Deletion of a xenobiotic metabolizing gene in mice affects folate metabolism Biochem. Biophys. Res. Commun. 364 2007 556 560
39. G.M. Gray J.T. Cohen G. Cunha C. Hughes E.E. McConnell L. Rhomberg Weight of the evidence evaluation of low-dose reproductive and developmental effects of bisphenol A Hum. Ecol. Risk Assess. 10 2004 875 921
40. A. Takeshita N. Koibuchi J. Oka M. Taguchi Y. Shishiba Y. Ozawa Bisphenol-A, an environmental estrogen, activates the human orphan nuclear receptor, steroid and xenobiotic receptor-mediated transcription Eur. J. Endocrinol. 145 2001 513 517
41. S. Safe S. Papineni The role of xenoestrogenic compounds in the development of breast cancer Trends Pharmacol. Sci. 27 2006 447 454
42. E.A. Ariazi V.C. Jordan Estrogen-related receptors as emerging targets in cancer and metabolic disorders Curr. Top. Med. Chem. 6 2006 181 193
43. X. Li S. Zhang S. Safe Activation of kinase pathways in MCF-7 cells by 17beta-estradiol and structurally diverse estrogenic compounds J. Steroid Biochem. Mol. Biol. 98 2006 122 132
44. R.L. Rich L.R. Hoth K.F. Geoghegan T.A. Brown P.K. LeMotte S.P. Simons Kinetic analysis of estrogen receptor/ligand interactions Proc. Natl. Acad. Sci. U.S.A. 99 2002 8562 8567
45. M. Maggiolini D. Bonofiglio S. Marsico M.L. Panno B. Cenni D. Picard Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells Mol. Pharmacol. 60 2001 595 602
46. E.R. Kisanga J. Gjerde A. Guerrieri-Gonzaga F. Pigatto A. Pesci-Feltri C. Robertson Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial Clin. Cancer Res. 10 2004 2336 2343
47. A. Mushtaq M. Payton E. Sim The COOH terminus of arylamine N -acetyltransferase from Salmonella typhimurium controls enzymic activity J. Biol. Chem. 277 2002 12175 12181
48. J.D. Thompson D.G. Higgins T.J. Gibson CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice Nucleic Acids Res. 22 1994 4673 4680
49. J.C. Sinclair J. Sandy R. Delgoda E. Sim M.E. Noble Structure of arylamine N -acetyltransferase reveals a catalytic triad Nat. Struct. Biol. 7 2000 560 564